ABC has been the subject of several other research reports. JPMorgan Chase & Co. reaffirmed a neutral rating and issued a GBX 678 ($8.53) price target on shares of Abcam Plc in a report on Wednesday, January 4th. Peel Hunt reaffirmed a hold rating and issued a GBX 750 ($9.44) price target on shares of Abcam Plc in a report on Friday, February 24th. Finally, Numis Securities Ltd reaffirmed a hold rating and issued a GBX 912 ($11.48) price target on shares of Abcam Plc in a report on Friday, March 17th. One analyst has rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. The company has an average rating of Hold and a consensus target price of GBX 819.20 ($10.31).
Abcam Plc (LON:ABC) traded down 0.36% on Thursday, reaching GBX 826.00. The company had a trading volume of 375,791 shares. The stock’s market capitalization is GBX 1.67 billion. Abcam Plc has a 1-year low of GBX 587.00 and a 1-year high of GBX 948.00. The stock’s 50 day moving average is GBX 854.11 and its 200-day moving average is GBX 836.38.
ILLEGAL ACTIVITY WARNING: This story was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/2485773/abcam-plcs-abc-sell-rating-reaffirmed-at-panmure-gordon.html.
The business also recently declared a dividend, which was paid on Thursday, April 13th. Investors of record on Thursday, March 16th were issued a GBX 2.83 ($0.04) dividend. The ex-dividend date was Thursday, March 16th. This represents a dividend yield of 0.31%.
In related news, insider Alan Thomas Hirzel purchased 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 22nd. The stock was purchased at an average price of GBX 809 ($10.18) per share, with a total value of £48,540 ($61,095.03).
Abcam Plc Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.